Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns.
Gougis P, Grandal B, Jochum F, Bihan K, Coussy F, Barraud S, Asselain B, Dumas E, Sebbag C, Hotton J, Spaggiari E, Pierga JY, Savarino R, Laas E, Spano JP, Reyal F, Hamy AS. Gougis P, et al. Among authors: laas e. JAMA Netw Open. 2023 Oct 2;6(10):e2339934. doi: 10.1001/jamanetworkopen.2023.39934. JAMA Netw Open. 2023. PMID: 37883083 Free PMC article.
Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study.
Hanvic B, Lecuru F, Vanacker H, Pautier P, Narducci F, Cherifi F, Floquet A, Angeles MA, Berton D, Pomel C, Kalbacher E, Provansal M, Fernandez Y, Rouge TM, Roméo C, Laas E, Morice P, Hudry D, Meriaux E, Guyon F, Illac-Vauquelin C, Selle F, Meeus P, Genestie C, Salleron J, Ray-Coquard I. Hanvic B, et al. Among authors: laas e. Gynecol Oncol. 2023 Jul;174:190-199. doi: 10.1016/j.ygyno.2023.05.014. Epub 2023 May 19. Gynecol Oncol. 2023. PMID: 37210929
Effects of gender and socio-environmental factors on health-care access in oncology: a comprehensive, nationwide study in France.
Jochum F, Hamy AS, Gougis P, Dumas É, Grandal B, Laas E, Feron JG, Gaillard T, Girard N, Pauly L, Gauroy E, Darrigues L, Hotton J, Lecointre L, Reyal F, Akladios C, Lecuru F. Jochum F, et al. Among authors: laas e. EClinicalMedicine. 2023 Nov 1;65:102298. doi: 10.1016/j.eclinm.2023.102298. eCollection 2023 Nov. EClinicalMedicine. 2023. PMID: 37965434 Free PMC article.
Evolution of synchronous female bilateral breast cancers and response to treatment.
Hamy AS, Abécassis J, Driouch K, Darrigues L, Vandenbogaert M, Laurent C, Zaccarini F, Sadacca B, Delomenie M, Laas E, Mariani O, Lam T, Grandal B, Laé M, Bieche I, Vacher S, Pierga JY, Brain E, Vallot C, Hotton J, Richer W, Rocha D, Tariq Z, Becette V, Meseure D, Lesage L, Vincent-Salomon A, Filmann N, Furlanetto J, Loibl S, Dumas E, Waterfall JJ, Reyal F. Hamy AS, et al. Among authors: laas e. Nat Med. 2023 Mar;29(3):646-655. doi: 10.1038/s41591-023-02216-8. Epub 2023 Mar 6. Nat Med. 2023. PMID: 36879128 Free PMC article.
Impact of the Area of Residence of Ovarian Cancer Patients on Overall Survival.
Jochum F, Hamy AS, Gaillard T, Lecointre L, Gougis P, Dumas É, Grandal B, Feron JG, Laas E, Fourchotte V, Girard N, Pauly L, Osdoit M, Gauroy E, Darrigues L, Reyal F, Akladios C, Lecuru F. Jochum F, et al. Among authors: laas e. Cancers (Basel). 2022 Dec 4;14(23):5987. doi: 10.3390/cancers14235987. Cancers (Basel). 2022. PMID: 36497469 Free PMC article.
Exploring the added value of pretherapeutic MR descriptors in predicting breast cancer pathologic complete response to neoadjuvant chemotherapy.
Malhaire C, Selhane F, Saint-Martin MJ, Cockenpot V, Akl P, Laas E, Bellesoeur A, Ala Eddine C, Bereby-Kahane M, Manceau J, Sebbag-Sfez D, Pierga JY, Reyal F, Vincent-Salomon A, Brisse H, Frouin F. Malhaire C, et al. Among authors: laas e. Eur Radiol. 2023 Nov;33(11):8142-8154. doi: 10.1007/s00330-023-09797-5. Epub 2023 Jun 15. Eur Radiol. 2023. PMID: 37318605
Percutaneous Uterine Needle Biopsy with Microscopic and Array-CGH Analyses for Preoperative Sarcoma Diagnosis in Patients with Suspicious Myometrial Tumors on MRI: A Prospective Pilot Study (SARCGYN).
Smadja J, El Zein S, Pierron G, Watson S, Laas E, Ramtohul T, Tzanis D, Servois V, Bonvalot S. Smadja J, et al. Among authors: laas e. Ann Surg Oncol. 2023 Feb;30(2):943-953. doi: 10.1245/s10434-022-12697-5. Epub 2022 Oct 26. Ann Surg Oncol. 2023. PMID: 36287348
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial.
Rodrigues M, Vanoni G, Loap P, Dubot C, Timperi E, Minsat M, Bazire L, Durdux C, Fourchotte V, Laas E, Pouget N, Castel-Ajgal Z, Marret G, Lesage L, Meseure D, Vincent-Salomon A, Lecompte L, Servant N, Vacher S, Bieche I, Malhaire C, Huchet V, Champion L, Kamal M, Amigorena S, Lantz O, Chevrier M, Romano E. Rodrigues M, et al. Among authors: laas e. Nat Commun. 2023 Jun 22;14(1):3698. doi: 10.1038/s41467-023-39383-8. Nat Commun. 2023. PMID: 37349318 Free PMC article. Clinical Trial.
114 results